Superworth

biote BTMD

Chemicals, Basic Materials
$1.07
−1.83%
Market cap
$38.4M
PE
10.7×
5y median 12.3×
Forward PE
n/m
not a meaningful number
Price to sales
0.2×
EV/EBIT
10.5×
Revenue, 12 months
$183.5M
−8% on a year ago
Net margin
3.2%
Free cash flow yield
n/m
a yield above 40% (usually a one-off)

biote trades at 10.7× trailing earnings, near its ten-year median. Revenue was $183.5M over the last twelve months, down 8% on a year earlier with a 3% net margin.

Charts

Financials

Income statement for BTMD, by quarter
Income statementQ3 FY23Q4 FY23Q1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
$45.6M+9%$45.7M+3%$46.8M+4%$49.2M−0%$51.4M+13%$49.8M+9%$49M+5%$48.9M−1%$48M−7%$46.4M−7%$44.9M−8%$44.2M−10%
Cost of revenue$14.2M+6%$14M−9%$13.5M−3%$15.4M−3%$15.3M+8%$14M+0%$12.6M−6%$13.9M−10%$13.5M−11%$14.8M+6%$14M+11%$15.3M+10%
Gross profit$31.4M+10%$31.7M+9%$33.4M+8%$33.8M+1%$36.1M+15%$35.8M+13%$36.4M+9%$35M+4%$34.4M−5%$31.6M−12%$31M−15%$28.9M−17%
SG&A$23.8M+14%$26.2M+20%$22.9M−1%$27.6M+7%$23.9M+1%$33M+26%$26.7M+16%$24.2M−12%$26.2M+9%$24.7M−25%$27.8M+4%$32.4M+34%
$7.6M−3%$5.5M−25%$10.4M+32%$6.2M−19%$12.2M+60%$2.8M−50%$9.7M−7%$10.8M+73%$8.3M−32%$6.8M+147%$3.2M−67%−$3.5M
Interest expense$1.5M+9%$1.5M−2%$1.7M+1%$2.6M+57%$3.5M+132%$3.2M+109%$2.9M+75%$2.9M+11%$2.7M−23%$2.5M−23%$2M−32%$2.2M−24%
Pre-tax income$23.5M+3130%$9.3M−30%−$3.3M−84%−$10.3M−15%$15.9M−33%−$1.2M$17.5M$6.1M$8.5M−47%$5.6M$3.3M−81%−$7.1M
$3.9M+1556%−$2.7M$2.4M+281%$73K−92%$3.2M−17%−$4.7M+71%$1.6M−33%$2.1M+2845%−$765K$3M$662K−59%$296K−86%
Net income$7.5M+50100%$7.7M+377%−$4.2M−39%−$7.1M+38%$10.7M+42%$3.7M−52%$13.7M$3.2M$8.2M−24%$2M−47%$2.3M−83%−$6.6M
$0.24$0.23+35%−$0.12−69%−$0.21−16%$0.33+38%$0.10−57%$0.37$0.10$0.22−33%$0.05−50%$0.06−84%−$0.23
31M+308%34M+260%34.6M+97%33.1M+60%32.3M+4%37.4M+10%37M+7%31.7M−4%36.7M+14%36M−4%36M−3%28.6M−10%

Gross profit: 21 periods, Q2 FY21 to Q2 FY26: not printed by the filing, worked out from its own lines.

EPS, diluted: 5 periods, Q4 FY21 to Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: Q4 FY21: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. 4 periods, Q4 FY22 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Basic Materials nearest biote's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
BTMDbiote$38.4M10.7×12.3×0.2×−8%3.2%
BWENBroadwind$68.6Mn/m12.9×0.5×+17%3.9%
FTLFFitlife Brands$78.4M13.5×15.3×0.8×+61%6.2%
SMIDSmith Midland$112.9M14.7×18.2×1.3×−2%8.6%
NAGENiagen Bioscience$192.3M13.5×27.0×1.5×+11%12.4%
SNDSmart Sand$201.8M18.3×12.5×0.5×+27%2.7%
ALTOAlto Ingredients$280M5.4×13.8×0.3×+1%5.5%
FRDFriedman Industries$301.7M10.9×9.3×0.4×+62%3.6%
IDRIdaho Strategic Resources$303.5M13.5×25.5×6.0×+67%44.0%
VFFVillage Farms International$314.9M14.3×18.3×1.4×−3%9.8%
Peer median$201.8M13.5×15.3×0.8×+17%6.2%

More on biote

Each number over time

Where it ranks

Its groups

About

Industry
Chemicals
Sector
Basic Materials

Valuation data, not investment advice. Prices as of .